151
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Oestrogen receptor β5 and epidermal growth factor receptor synergistically promote lung cancer progression

, , , , , & ORCID Icon show all
Pages 157-165 | Received 03 Apr 2018, Accepted 06 Jun 2018, Published online: 19 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lecai Xiong, Yanhong Wei, Xiao Zhou, Peng Dai, Yi Cai, Xuefeng Zhou, Ming Xu, Jinping Zhao & Hexiao Tang. (2021) AGTR1 Inhibits the Progression of Lung Adenocarcinoma. Cancer Management and Research 13, pages 8535-8550.
Read now

Articles from other publishers (3)

Peng Dai, Yanhong Wei, Lecai Xiong, Xiao Zhou, Xuefeng Zhou, Ming Xu, Jinping Zhao & Hexiao Tang. (2023) The change of eosinophils in the perioperative period is significantly associated with the prognosis in patients with lung cancer. Future Oncology 19:13, pages 925-936.
Crossref
Lijuan Zhang, Meng Tian, Jiamao Lin, Jianbo Zhang, Haiyong Wang & Zhenxiang Li. (2021) Estrogen Receptor β1 Expression Patterns Have Different Effects on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors’ Treatment Response in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma. Frontiers in Oncology 10.
Crossref
Jan-Ake Gustafsson, Anders Strom & Margaret Warner. (2019) Update on ERbeta. The Journal of Steroid Biochemistry and Molecular Biology 191, pages 105312.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.